About Lei Cai
Form D filings for Neurock Pharmaceuticals in 2024 list Lei Cai as CEO.
Lei Cai first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Lei Cai in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Lei Cai works with at each company, as listed on that company's latest Form D.
Neurock Pharmaceuticals Inc. · Form D, Mar 11, 2024
HW
Haixing Wang
Executive officer
QW
Qingxi Wang
Director